Literature DB >> 19508293

BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution.

Ulf Thunberg, Rose-Marie Amini, Johan Linderoth, Göran Roos, Gunilla Enblad, Mattias Berglund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19508293     DOI： 10.1111/j.1365-2141.2009.07762.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.

Authors:  John T Sandlund; Mike G Martin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Nathalie A Johnson; Graham W Slack; Kerry J Savage; Joseph M Connors; Susana Ben-Neriah; Sanja Rogic; David W Scott; King L Tan; Christian Steidl; Laurie H Sehn; Wing C Chan; Javeed Iqbal; Paul N Meyer; Georg Lenz; George Wright; Lisa M Rimsza; Carlo Valentino; Patrick Brunhoeber; Thomas M Grogan; Rita M Braziel; James R Cook; Raymond R Tubbs; Dennis D Weisenburger; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Christina Holcroft; Elaine S Jaffe; Louis M Staudt; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

Review 3.  Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck.

Authors:  A Auerbach; J J Schmieg; N S Aguilera
Journal:  Head Neck Pathol       Date:  2021-03-15

4.  New prognostic models for extranodal natural killer T-cell lymphoma, nasal-type using Cox regression and machine learning.

Authors:  Jianbin Sun; Xiaoyan Ke; Mingzhi Zhang; Yuhui Wang; Fengyang An; Yulin Zhao; Li Zhu
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.